-+ 0.00%
-+ 0.00%
-+ 0.00%

BIOLINERX AND HEMISPHERIAN PRESENT PRECLINICAL DATA DEMONSTRATING SYNERGY OF GLIX1 WITH PARP INHIBITORS IN HR-PROFICIENT OVARIAN CANCER AT ESMO 2026

Reuters·10/23/2026 11:02:19